Δημοσιεύσεις σχετικές με την αντιμετώπιση της καρδιακής ανεπάρκειας και με εμφύτευση βηματοδοτών, απινιδωτών και αμφικοιλιακών συστημάτων

Pacing /Cardiac resynchronisation therapy (CRT)- Βηματοδότηση/θεραπεία καρδιακού επανασυγχρονισμού

  1. Η συμβολή της τεχνητής καρδιακής βηματοδότησης στη θεραπεία των καρδιαγγειακών παθήσεων. Μάντζιαρη Λ. Μεταπτυχιακή διπλωματική εργασία, Θεσσαλονίκη 2006
  2. General anesthesia versus sedation for implantation of a biventricular pacing device for cardiac resynchronization therapy. Theron P, Guha K,Mantziari L, Salahuddin S, Sharma R, Jaggar S. J Cardiothorac Vasc Anesth. 2014 Apr;28(2):280-4.
  3. The impact of age on clinical outcomes following cardiac resynchronisation therapy. Guha K, Konstantinou D,Mantziari L, Modi BN, Chandrasekaran B, Khalique Z, McDonagh T, Sharma R. J Interv Card Electrophysiol. 2014 Jan;39(1):95-102.
  4. QRS analysis using wavelet transformation for the prediction of response to cardiac resynchronization therapy: a prospective pilot study. Vassilikos VP,Mantziari L, Dakos G, Kamperidis V, Chouvarda I, Chatzizisis YS, Kalpidis P, Theofilogiannakos E, Paraskevaidis S, Karvounis H, Mochlas S, Maglaveras N, Styliadis IH. J Electrocardiol. 2014 Jan-Feb;47(1):59-65.
  5. Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis. Mantziari L, Guha K, Khalique Z, McDonagh T, Sharma R. Am J Cardiol. 2012 Jun 1;109(11):1619-25.
  6. A reduction in total isovolumic time with cardiac resynchronisation therapy is a predictor of clinical outcomes. Guha K,Mantziari L, Sharma R, McDonagh TA, Gibson D, Duncan AM. Int J Cardiol. 2013 Sep 20;168(1):382-7.
  7. Cardiac resynchronization therapy for critically ill patients with left ventricular systolic dysfunction. Mantziari L, Guha K, Senguttuvan NB, Sharma R. Int J Cardiol. 2013 Feb 20;163(2):141-5. doi: 10.1016/j.ijcard.2011.05.034. Epub 2011 Jun 12.
  8. Persistent left superior vena cava. Report of 3 patients undergoing device implantation. Paraskevaidis S, Konstantinou DM, Theofilogiannakos E,Mantziari L, Tachmatzidis D, Kolettas V, Hadjimiltiades S, Styliadis I. Herz. 2014 Feb;39(1):163-5.
  9. Worsening heart failure as the main manifestation of neglected complete extrusion of a cardiac resynchronization therapy pacemaker. Vassilikos VP, Mantziari AA, Stavropoulos G, Styliadis IH. Cardiology. 2010;117(4):243-5.
  10. Indications for permanent pacing and pacing mode prescription from 1989 to 2006. Experience of a single academic centre in Northern Greece. Styliadis IH, Mantziari AP, Gouzoumas NI, Vassilikos VP, Paraskevaidis SA, Mochlas ST, Boufidou AI, Parcharidis GE. Hellenic J Cardiol. 2008 May-Jun;49(3):155-62.
  11. Guha K., Mantizari L., Mcdonagh T., Sharma R., Gibson D., Duncan A. A Reduction in Total Isovolumic Time with Cardiac Resynchronisation Therapy Is a Predictor of Clinical Outcomes. – London, GBR. Cardiostim 2012
  12. T. Parissis1, N. Kaldoglou1, L. Mantziari2, I. Ikonomidis1, M. Nikolaou1, A. Mebazaa3, J. Delgado4, M. Anastasiou-Nana1, F. Follath Gender-related differences in medical treatment and co-morbidities in patients with acute heart failure. Poster in ESC 2012 Munich Citation: European Heart Journal ( 2012 ) 33 ( Abstract Supplement ), 334
  13. K Guha1, A Vazir1, E Ridha1, L Mantziari1, R Yadav1, U Rosendahl1, MR Cowie1, R Sharma1, S Price1 A pilot study of optimisation of cardiac output and stroke volume using temporary epicardial pacing systems in a cardiothoracic intensive care unit. Citation: European Heart Journal: Acute Cardiovascular Care Abstract Supplement ( 2012 ) 1 ( S1 ), 133
  14. Mantziari L; Vassilikos V; Kamperidis V; Paraskevaidis S; Dakos G; Chatzizisis Y; Giannakoulas G; Karvounis H; Styliadis IH. Long term outcomes in ischaemic versus non-ischaemic dilated cardiomyopathy after cardiac resynchronization therapy. ICPES Athens 2011 , cited in Pacing and Clinical Electrophysiology Volume 34, Issue 11, pages 1362–1451, November 2011
  15. Vassilikos, L. Mantziari, V. Kamperidis, G. Dakos, P. Kalpidis, Y.S. Chatzizisis, G. Giannakoulas, S. Paraskevaidis, I.H. Styliadis. QRS decomposition using the morlet wavelet transformation as a novel tool for predicting response to cardiac resynchronization therapy. ESC Paris 2011. Cited in Eur Heart J (2011)32(suppl 1):1-312doi:10.1093/eurheartj/ehr322
  16. Mantziari, K.Guha, R.Sharma. Dosing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in patients receiving cardiac resynchronization therapy and its impact on long term outcomes. Poster Presentation ESC Heart Failure Congress 2011, Gothenburg
  17. Guha, A. Mantziari, Z. Khalique, T. McDonagh, MR Cowie, R.Sharma. The impact of a specialist heart failure pacing clinic upon the management of patients treated with cardiac resynchronization therapy. Poster Presentation ESC Heart Failure Congress 2011, Gothenburg
  18. Kamperidis, S.Paraskevaidis, V. Vassilikos, KN. Tsilonis. E.Theofilogiannakos, L. Mantziari, G.Dakos, S.Stavropoulos. IH Styliadis. Implantable cardioverter-defibrillator therapy in Brugada syndrome: Long term follow up of prophylactic implantation. XIV International symposium on progress in clinical pacing, ROME 2010
  19. Tsilonis, V. Vassilikos, A. Vosnakidis, L. Mantziari, S.Paraskevaidis, G.Dakos, S. Stavropoulos,G. Efthimiadis, S. Mochlas, G. Louridas, G. Parcharidis, IH. Styliadis. Practice patterns and efficacy of implantable cardioverter defibrillator implantations in a tertiary centre of Northern Greece. XIV International symposium on progress in clinical pacing, ROME 2010

 

 

Καρδιακή ανεπάρκεια

  1. Η σημασία νέων δεικτών στην εκτίμηση της ιδιοπαθούς διατατικής μυοκαρδιοπάθειας. Μάντζιαρη Λ. Διδακτορική διατριβή, ΑΠΘ, Θεσσαλονίκη 2012
  2. Gender-related differences in patients with acute heart failure: management and predictors of in-hospital mortality. Parissis JT,Mantziari L, Kaldoglou N, Ikonomidis I, Nikolaou M, Mebazaa A, Altenberger J, Delgado J, Vilas-Boas F, Paraskevaidis I, Anastasiou-Nana M, Follath F.Int J Cardiol. 2013 Sep 20;168(1):185-9.
  3. NGAL and ST2 levels in ambulatory patients with chronic heart failure. Clinical and echocardiographic correlates. Ventoulis I/Mantziari L, Mouratoglou SA, Kamperidis V, Giannakoulas G, Ziakas A, Tsalikakis D, Giamouzis G, Hitoglou-Makedou A, Karvounis H. Scand Cardiovasc J. 2015 Aug;49(4):213-9.
  4. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Triposkiadis FK, Butler J, Karayannis G, Starling RC, Filippatos G, Wolski K, Parissis J, Parisis C, Rovithis D, Koutrakis K, Skoularigis J, Antoniou CK, Chrysohoou C, Pitsavos C, Stefanadis C, Nastas J, Tsaknakis T,Mantziari L, Giannakoulas G, Karvounis H, Kalogeropoulos AP, Giamouzis G. Int J Cardiol. 2014 Mar 1;172(1):115-21.
  5. Increased right atrial volume index predicts low Duke activity status index in patients with chronic heart failure. Mantziari L, Kamperidis V, Ventoulis I, Damvopoulou E, Giannakoulas G, Efthimiadis G, Paraskevaidis S, Vassilikos V, Ziakas A, Karvounis H, Styliadis IH. Hellenic J Cardiol. 2013 Jan-Feb;54(1):32-8.
  6. Differences in Clinical Presentation and Findings between Idiopathic Dilated and Ischaemic Cardiomyopathy in an Unselected Population of Heart Failure Patients. Mantziari L, Ziakas A, Ventoulis I, Kamperidis V, Lilis L, Katsiki N, Karavasiliadou S, Kiraklidis K, Pliakos C, Gemitzis K, Karvounis H, Styliadis IH. Open Cardiovasc Med J. 2012;6:98-105. Epub 2012 Sep 7.
  7. Somatostatin analogue scintigraphy in a patient with viral myocarditis.Moralidis E,Mantziari L, Gerasimou G, Styliadis IH, Gotzamani-Psarrakou A. Hell J Nucl Med. 2012 May-Aug;15(2):144-6. doi: 10.1967/s002449910031. Epub 2012 Jun 27.
  8. Theron P.S., Guha K., Mantziari L., Salahuddin S., Sharma R. & Jaggar S.I. Anesthesia for patients with heart failure.NYSSA New York 2011
  9. T. Parissis, M. Nikolaou, N. Kaldoglou, A. Mantziari,A. Mebazaa, I. Ikonomidis, J. Delgado , F. Vilas-Boas, M. Anastasiou-Nana, F. Follath. Gender-related differences in patients with acute heart failure: clinical characteristics and predictors of in-hospital mortality. ESC Paris 2011. Cited in Eur Heart J (2011)32(suppl 1):1-312
  10. Mantziari, V.Kamperidis, E.Damvopoulou, I.Ventoulis, G. Giannakoulas, S.Paraskevaidis, V. Vassilikos, H.Karvounis, IH Styliadis. Myocardial isovolumic acceleration as an index of right ventricular contractile function in heart failure patients. ESC Heart Failure Congress 2011, Gothenbur

 

Επιστροφή στο Βιογραφικό της ιατρού Δρ. Λίλιαν Μάντζιαρη

Σε μορφή pdf μπορείτε να το κατεβάσετε από εδώ